Profile

John H. Stewart IV, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

92 Ratings
5 Comments

John H. Stewart IV, M.D.

Vice Chair, Surgical Sciences
Associate Director,
Program Director,
Associate Professor,



Clinical Specialties

Sarcoma, Gastrointestinal Oncology Surgery, Peritoneal Surface Malignancies, Tumor Immunotherapy, Breast Cancer Surgery, Melanoma

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4276
Department: 336-716-0545

Email: jhstewar@wakehealth.edu

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.S., Louisiana Technical University , 1991
  • M.D., Howard University , 1995
  • Residency, Surgery, Temple Univ Hosp, 1998
  • Fellowship, Natl Cancer Institute (NIH), 1999
  • Fellowship, Surgery, Natl Cancer Institute (NIH), 2002
  • Residency, Surgery, Vanderbilt Univ Medical Center, 2004

Board Certifications

  • American Board of Surgery, Surgery, Surgery - Surgery

NPI Number

  • 1851374383
John H. Stewart IV, M.D.

Doctor Rating

4.6 out of 5

92 Ratings
5 Comments

John H. Stewart IV, M.D.

Vice Chair, Surgical Sciences
Associate Director, Comprehensive Cancer Center
Program Director, Surgery, General
Associate Professor, Surgery, General
Comprehensive Cancer Center
Maya Angelou Center for Health Equity
Translational Science Institute

Research Interests

cancer/oncogenesis, drugs/therapeutic agents pharm, education/training (all f, t,, minority health issues

Contact Information

Academic: 336-716-0545 | Department: 336-716-0545

Email: jhstewar@wakehealth.edu

Media Medical Expert »

Recent Publications

Levine EA, Stewart JH IV, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573-585.

Votanopoulos KI, Randle RW, Craven B, Swett KR, Levine EA, Shen P, Stewart JH, Mirzazadeh M. Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21(3):868-874.

Randle RW, Swett KR, Swords DS, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol. 2014;21(5):1474-1479.

Blackham AU, Northrup SA, Willingham M, Sirintrapun J, Russell GB, Lyles DS, Stewart JH IV. Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma. J Surg Res. 2014;187(2):412-426.

Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, Votanopoulos K, Stewart JH, Shen P, Levine EA. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2014;109(7):740-745.

Ahmed S, Levine EA, Swett KR, Randle RW, Shen PW, Stewart JH, Votanopoulos KI. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S135.

Votanopoulos KI, Russell G, Randle RW, Shen PW, Stewart JH, Levine EA. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S128-S129.

Randle RW, Swett KR, Stewart JH, Shen P, Levine EA, Votanopoulos KI. Morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with diabetes [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S87.

Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M,. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014;21(5):1501-1505.

Sirintrapun SJ, Blackham AU, Russell G, Votanopoulos K, Stewart JH, Shen P, Levine EA, Geisinger KR, Bergman S. Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol. 2014;():.

Blackham AU, Russell GB, Stewart JH IV, Votanopoulos K, Levine EA, Shen P. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;():.


Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res. 2013;179(1):e133-e139.

Blackham AU, Northrup SA, Willingham M, D'Agostino RB Jr, Lyles DS, Stewart JH IV. Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus. Surgery. 2013;153(3):333-343.

Addington E, Russell G, Tedeschi R, Levine E, Shen P, Stewart J, Danhauer S, Duckworth K, McQuellon R. Post-traumatic growth is sustained two years after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [abstract]. Psychooncology. 2013;22(Suppl 2):54.

Sirintrapun J, Blackham A, Russell G, Stewart J, Shen P, Levine E, Geisinger K, Bergman S, Cimic A. Significance of signet-ring cells in extracellular mucin pools versus tissue in high-grade mucinous carcinoma peritonei [abstract]. Lab Invest. 2013;93(Suppl 1):180A.

Votanopoulos KI, Swett K, Blackham AU, Ihemelandu C, Shen P, Stewart JH, Levine EA. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer. Ann Surg Oncol. 2013;20(4):1088-1092.

Howard-McNatt M, Lawrence J, Melin SA, Levine EA, Shen P, Stewart JH IV. Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer. Am J Surg. 2013;205(4):397-401.

Ahmad T, Song E, Russell G, Howard-McNatt M, Bell RA, Stewart JH. An analysis of disparities in surgical oncology trials for lung cancer [abstract]. Ann Surg Oncol. 2013;20(Suppl 1):S117.

Blackham A, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger K, Votanopoulos KI, Stewart JH, Shen P, Levine E. Perioperative systemic chemotherapy for metastatic appendiceal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [abstract]. Ann Surg Oncol. 2013;20(Suppl 1):S13.

Randle RW, Swett KR, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis. Am Surg. 2013;79(6):620-624.

Sun Y, Shen P, Stewart JH, Russell GB, Levine EA. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma. Am Surg. 2013;79(6):644-648.

Votanopoulos KI, Swett K, Swords DS, Shen P, Stewart JH, Levine E. Obesity and peritoneal surface disease outcomes following cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) [abstract]. Ann Surg Oncol. 2013;20(Suppl 1):S113.


Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, Levine EA. Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. Ann Surg Oncol. 2013;20(11):3497-3503.

Votanopoulos KI, Swords DS, Swett KR, Randle RW, Shen P, Stewart JH, Levine EA. Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors. Ann Surg Oncol. 2013;20(12):3899-3904.

Randle RW, Northrup SA, Sirintrapun SJ, Lyles DS, Stewart JH. Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors. Surgery. 2013;154(6):1323-1330.

Neal MT, Chan MD, Lucas JT Jr, Loganathan A, Dillingham C, Pan E, Stewart JH IV, Bourland JD, Shaw EG, Tatter SB, Ellis TL. Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg. 2013;():.

Carroll DL, Stewart JH IV, Levi-Polyachenko NH, inventors; Wake Forest University Health Sciences, assignee. Compositions and methods for treating cancer. United States patent US 8,501,233. 2013 Aug 6. 2013;():.

Howard-McNatt M, Geisinger KR, Stewart JH IV, Shen P, Levine EA. Is intraoperative imprint cytology evaluation still feasible for the evaluation of sentinel lymph nodes for lobular carcinoma of the breast?. Ann Surg Oncol. 2012;19(3):929-934.

Craven B, Shen P, Levine E, Votanopoulos K, Stewart J, Mirzazadeh M. Urologic recostructive [sic] procedures in cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) for peritoneal surface malignancy in 934 consecutive procedures [abstract]. Neurourol Urodyn. 2012;31(2):287.

McQuellon R, Duckworth K, Russell G, Shen P, Stewart J, Votanopoulos K, Levine E. After screening for depression in a high risk medical population: then what? [abstract]. Psychooncology. 2012;21(Suppl 1):126-127.

Kimmick GG, Camacho F, Hwang W, Mackley H, Stewart J, Anderson RT. Adjuvant radiation and outcomes after breast conserving surgery in publicly insured patients. J Geriatr Oncol. 2012;3(2):138-146.

Levine EA, Blazer DG III, Kim MK, Shen P, Stewart JH IV, Guy C, Hsu DS. Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J Am Coll Surg. 2012;214(4):599-607.

Duckworth KE, McQuellon RP, Russell GB, Cashwell CS, Shen P, Stewart JH IV, Levine EA. Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC). J Surg Oncol. 2012;106(4):376-380.

Newman NA, Votanopoulos KL, Stewart JH, Shen P, Levine EA. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer. Minerva Chir. 2012;67(4):309-318.

Votanopoulos KI, Shen P, Stewart JH IV, Levine EA. Current status and future directions in appendiceal cancer with peritoneal dissemination. Surg Oncol Clin N Am. 2012;21(4):599-609.

Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215(3):412-417.

Baker JJ, Newman NA, Levine EA, Deal AM, Frank JS, Stewart JH, Shen P, Meyers MO. Utility of routine PET/CT for initial staging of patients with sentinel lymph node positive melanoma [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S127.

Blackham A, Russell GB, Stewart JH, Votanopoulos K, Levine EA, Shen P. Decreased survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy compared to hepatic resection for metastatic colorectal cancer [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S95-S96.

Blackham A, Northrup SA, Stewart JH. Mechanisms of resistance to oncolytic vesicular stomatitis virus in malignant melanoma [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S47.

Dougherty S, Urbanic J, Stewart J, Levine E, Howard-McNatt M. Is radiation indicated in patients with T1-T2 breast cancer with close or positive margins after mastectomy? [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S86-S87.

Griffith KF, Levine EA, Shen P, Stewart JH, Votanopoulas KI [sic] [Votanopoulos KI], Russell GB, Geisinger K. Appendiceal neuroendocrine tumors with peritoneal surface dissemination treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S109.

Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, McQuellon R, Russell G, Levine EA. Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS plus HIPEC) with preoperative FACT - C (Functional Assessment of Cancer Therapy) and patient rated performance status [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S16.

Ihemelandu CU, Russell G, Shen P, Stewart JH, Votanopoulos K, Levine EA. Impact of lymph node metastasis on survival outcome for patients diagnosed with mucinous carcinoma of the appendix: the role of right hemicolectomy [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S98.

Shen P, Gahagan J, Stewart JH, Votanopoulus K [sic] [Votanopoulos K], Swett K, Levine EA. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: analysis of postoperative morbidity and mortality from a high volume center [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S141.

Votanopoulos KI, Shen P, Stewart JH, Russell G, Levine EA, Newman NA. Cytoreductive surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in the elderly [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S100-S101.


Kimmick G, Camacho F, Hwang W, Mackley H, Stewart J, Anderson R. Higher overall mortality and local recurrence, but not breast cancer events, related to lack of radiation after breast conserving surgery [abstract]. Am J Clin Oncol. 2011;34(2):198-199.

Becher RD, Shen P, Stewart JH, Russell G, Bradley JF, Levine EA. Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy. J Gastrointest Oncol. 2011;2(2):70-76.

Duckworth K, McQuellon R, Russell G, Levine E, Shen P, Stewart J, Cromer M, Cashwell C. Quality of life and sleep quality of long-term survivors of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [abstract]. Psychooncology. 2011;20(Suppl 1):79-80.

Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, Levine EA. Management of peritoneal carcinomatosis from colorectal cancer. Semin Oncol. 2011;38(4):568-575.

Parson EN, Lentz S, Russell G, Shen P, Levine EA, Stewart JH IV. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms. Am J Surg. 2011;202(4):481-486.

Winterich JA, Quandt SA, Grzywacz JG, Clark P, Dignan M, Stewart JH IV, Arcury TA. Men's knowledge and beliefs about colorectal cancer and 3 screenings: education, race, and screening status. Am J Health Behav. 2011;35(5):525-534.

Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH IV, Levine EA. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol. 2011;18(13):3673-3679.

Stewart JH IV, Levine EA. Role of bacillus Calmette-Guerin in the treatment of advanced melanoma. Expert Rev Anticancer Ther. 2011;11(11):1671-1676.

Stewart JH IV, Ahmed M, Northrup SA, Willingham M, Lyles DS. Vesicular stomatitis virus as a treatment for colorectal cancer. Cancer Gene Ther. 2011;18(12):837-849.

Becher RD, Shen P, Stewart JH, Russell G, Bradley T, Levine EA. Splenectomy ameliorates hematologic toxicity of intraperitoneal hyperthermic chemotherapy [abstract]. Ann Surg Oncol. 2010;17(Suppl 1):S83-S84.

Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH, Levine EA. Survival and health-related quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for disseminated peritoneal cancer of colonic origin [abstract]. Ann Surg Oncol. 2010;17(Suppl 1):S9.

Parson N, Shen P, Russell GB, Lentz SS, Levine EA, Stewart JH. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms [abstract]. Ann Surg Oncol. 2010;17(Suppl 1):S120.

Votanopoulos KI, Shen P, Stewart JH, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin-C [abstract]. Ann Surg Oncol. 2010;17(Suppl 1):S85.

Blackham AU, Shen P, Stewart JH, Russell GB, Levine EA. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin. Ann Surg Oncol. 2010;17(10):2720-2727.

Poletti M, Lewis R, Flowers M, Stewart JH. Survivors in Service (SIS) Breast Health Outreach and Navigation Program [abstract]. Am J Clin Oncol. 2010;33(5):530.

Esquivel J, Chua TC, Stojadinovic A, Melero JT, Levine EA, Gutman M, Howard R, Piso P, Shen P, Stewart JH, et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010;102(6):565-570.

Rohani P, Scotti SD, Shen P, Stewart JH, Russell GB, Cromer M, Levine EA. Use of FDG-PET imaging for patients with disseminated cancer of the appendix. Am Surg. 2010;76(12):1338-1344.

McQuellon R, Russell G, Campbell C, Duckworth K, Shen P, Stewart J, Fenstermaker J, Pruitt L, Cromer M, Levine E, et al. Assessing depressive symptoms with the Center for Epidemiologic Studies Depression Scale prior to cytoreductive surgery + intraperitoneal hyperthermic chemotherapy [abstract]. Psychooncology. 2009;18(Suppl 1):S42-S43.


Wood BC, David LR, Defranzo AJ, Stewart JH, Shen P, Geisinger KR, Marks MW, Levine EA. Impact of sentinel lymph node biopsy on immediate breast reconstruction after mastectomy. Am Surg. 2009;75(7):551-556.

Godat LN, Horton JK, Shen P, Stewart JH, Wentworth S, Levine EA. Recurrence after mastectomy for ductal carcinoma in situ. Am Surg. 2009;75(7):592-597.

Wong SL, Young YD, Geisinger KR, Shen P, Stewart JH, Sangueza O, Pichardo-Geisinger R, Levine EA. Intraoperative imprint cytology for evaluation of sentinel lymph nodes from Merkel cell carcinoma. Am Surg. 2009;75(7):615-619.

Becher RD, Shen P, Stewart JH, Geisinger KR, McCarthy LR, Levine EA. Sentinel lymph node mapping for gastric adenocarcinoma. Am Surg. 2009;75(8):710-714.

Levi-Polyachenko NH, Merkel EJ, Jones BT, Carroll DL, Stewart JH. Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes. Mol Pharm. 2009;6(4):1092-1099.




Stewart JH IV, Shen P, Levine EA. Translation considerations for hyperthermic intraperitoneal chemotherapy. Curr Probl Cancer. 2009;33(3):194-202.

Stewart JH IV, Levine EA, Shen P. The current role of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of appendiceal tumors. Curr Probl Cancer. 2009;33(3):142-153.

Stewart JH IV, Levine EA. Oncology In: O'Leary JP, Tabuenca A, Capote LR, eds. The physiologic basis of surgery. 4th ed. Philadelphia: Lippincott Williams & Wilkins;2008: 188-217.

Jackson LC, Camacho F, Levine EA, Anderson RT, Stewart JH IV. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina. Am J Surg. 2008;195(2):164-169.

McQuellon RP, Russell GB, Shen P, Stewart JH IV, Saunders W, Levine EA. Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol. 2008;15(1):125-133.

Shen P, Thai K, Stewart JH, Howerton R, Loggie BW, Russell G, Levine EA. Isolated metastases of colorectal cancer to the liver or peritoneum: outcomes associated with optimal surgical treatment [abstract]. Ann Surg Oncol. 2008;15(Suppl 2):6.

Stewart JH, Shen P, Fenstermaker J, McWilliams L, Merkle E, Jones B, Levine EA. A phase I trial of intraperitoneal hyperthermic chemoperfusion with oxaliplatin for the treatment of peritoneal surface dissemination of colorectal and appendiceal cancer [abstract]. Ann Surg Oncol. 2008;15(Suppl 2):23.

Stewart JH IV, Shen P, Russell G, Fenstermaker J, McWilliams L, Coldrun FM, Levine KE, Jones BT, Levine EA. A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers. Ann Surg Oncol. 2008;15(8):2137-2145.

Shen P, Stewart JH, Levine EA. Metastases of colorectal cancer to the liver and peritoneum: comparison of surgical paradigms. Expert Rev Anticancer Ther. 2008;8(11):1797-1808.

Stewart JH IV, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy: an evolving paradigm for the treatment of peritoneal surface malignancies. Expert Rev Anticancer Ther. 2008;8(11):1809-1818.

Shen P, Thai K, Stewart JH, Howerton R, Loggie BW, Russell GB, Levine EA. Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol. 2008;15(12):3422-3432.

Levi-Polyachenko NH, Carroll DL, Stewart JH IV. Applications of carbon-based nanomaterials for drug delivery in oncology In: Cataldo F, Da Ros T, eds. Medicinal chemistry and pharmacological potential of fullerenes and carbon nanotubes. Berlin: Springer;2008: 223-266.

Mondi MM, Cuenca RE, Ollila DW, Stewart JH, Levine EA. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol. 2007;14(1):218-221.

McQuellon RP, Danhauer SC, Russell GB, Shen P, Fenstermaker J, Stewart JH, Levine EA. Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 2007;14(3):1105-1113.

Jackson LC, Camacho F, Anderson RT, Stewart JH. Patterns of care analysis among women with DCIS in North Carolina [abstract]. Ann Surg Oncol. 2007;14(2 Suppl):41-42.

McQuellon RP, Russell GB, Shen P, Stewart JH, Saunders WW, Levine EA. Survival and quality of life (QOL) after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy (IPHC) for disseminated peritoneal cancer (PC) of appendiceal origin [abstract]. Ann Surg Oncol. 2007;14(2 Suppl):30-31.

Soo V, Bradley T, Shen P, Stewart JH, Russell GB, Levine EA. Splenectomy ameliorates hematologic toxicity of intraperitoneal hyperthermic chemotherapy [abstract]. Ann Surg Oncol. 2007;14(2 Suppl):116.

Stewart JH, Bertoni AE, Staten J, Shen P, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender, race/ethnicity and age-based disparities [abstract]. Ann Surg Oncol. 2007;14(2 Suppl):29.

Levine EA, Stewart JH IV, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204(5):943-955.

Soo V, Shen P, Pichardo R, Azzazy H, Stewart JH, Geisinger KR, Levine EA. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Ann Surg Oncol. 2007;14(5):1612-1617.

Stewart JH, Shen P, Levine EA. Patient selection for cytoreduction and hyperthermic intraperitoneal chemoperfusion In: Ceelen WP, ed. Peritoneal carcinomatosis: a multidisciplinary approach. New York: Springer;2007: 215-225.


Stewart JH, Shen P, Levine EA. Patient selection for cytoreduction and hyperthermic intraperitoneal chemoperfusion. Cancer Treat Res. 2007;134():215-229.

Kilpatrick LA, Shen P, Stewart JH, Levine EA. Use of sentinel lymph node biopsy for melanoma of the head and neck. Am Surg. 2007;73(8):754-758.

Stewart JH IV, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. J Surg Oncol. 2007;14(12):3328-3334.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Surgery, General

Clinical Specialties

Sarcoma, Gastrointestinal Oncology Surgery, Peritoneal Surface Malignancies, Tumor Immunotherapy, Breast Cancer Surgery, Melanoma
John H. Stewart IV, M.D.

John H. Stewart IV, M.D.

Vice Chair, Surgical Sciences
Associate Director, Comprehensive Cancer Center
Program Director, Surgery, General
Associate Professor, Surgery, General
Comprehensive Cancer Center
Maya Angelou Center for Health Equity
Translational Science Institute

Doctor Rating

4.6 out of 5

John H. Stewart IV, M.D.92 Ratings
5 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.6
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.6
Patients' confidence in CP
4.7
Time CP spent with patient
4.5
Wait time at clinic
3.9



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

6/13/2014

Great staff & doctor!

5/9/2014

Doctor or care giver take time with you & that counts so much.

5/1/2014

Excellent. Impressive.

4/21/2014

Very good bedside manner, easy to speak with, caring, personal!

4/3/2014

I would recommend *Dr. Stewart to anyone. I know that would need his service. He is awesome.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.